HCW Biologics Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
HCW Biologics Inc. (HCWB) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-31
- HCW Biologics Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- HCW Biologics Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- HCW Biologics Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- HCW Biologics Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2022-12-31 | $0.00 10-K/A · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |